Ono Pharmaceutical Co. Ltd. has opened a new 733-square-meter office in Zug, Switzerland to accommodate the company’s growth in Europe and partner markets. The occasion will be commemorated with a ceremony attended by company management.

“The opening of our new Zug office marks a key milestone in Deciphera’s journey. Following the Ono acquisition, we have significantly broadened our pipeline with several promising clinical candidates that have the potential to expand our commercial portfolio in the coming years. This office positions us for growth in international markets as we advance these candidates toward commercialization,” said Ryota Udagawa, President and CEO of Deciphera. “The Zug office plays a pivotal role as our hub in Europe, reinforcing our global footprint and enhancing our ability to better serve communities worldwide.”